The FDA has granted 510(k) clearance and to Parietex Optimized Composite mesh, a new version of the company's Parietex Composite mesh for open and laparoscopic ventral hernia repair, according to a release by Covidien.
The new version incorporates a more resistant barrier and a proprietary textile design with better visibility and increased strength than the original version. The new version is three times more resistant than the original and uses 3-D textile with x-stitch design that is stronger and enables better visibility through the mesh.
The original version was introduced in 1999 as the first hernia mesh to offer a resorbable collagen barrier and has been evaluated in over 45 clinical and pre-clinical studies.
Read the Covidien release on Parietex.
Related Articles on Hernia Repair:
Study: Children Exposed to Brief, Single Anesthetic Show No Long-Term Development Problems
10 Recent Anesthesia Findings and Breakthroughs
5 Recent Findings on Anesthesia in Children